Indication
Integrin αVβ3 Positive Tumors
1 clinical trial
1 product
Clinical trial
Therapeutic Efficiency and Response to 177Lu-AB-3PRGD2 in Patients With Integrin αVβ3 Positive TumorsStatus: Recruiting, Estimated PCD: 2024-10-30
Product
177Lu-AB-3PRGD2